Back to libraryHealing & Recovery

BPC-157

Research profile · How we handle evidence

BPC-157 (Body Protection Compound-157) is a 15–amino-acid peptide fragment originally identified in human gastric juice. In preclinical work, it has been studied for effects on wound healing and tissue repair in a range of models.

Evidence Score

58/100

Preclinical signal

Category

Healing & Recovery

Therapeutic area

Standard Dose

250-500mcg

1-2x daily

Half-life

~12 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

BPC-157 is a research peptide that’s been linked, mostly in animal studies, to faster-looking healing signals after injury. The strongest evidence base is preclinical, so any practical expectations should be conservative.

Mechanism of Action

Preclinical pathways discussed in the literature include FAK–paxillin signaling (linked to migration), growth-hormone receptor upregulation in fibroblasts, and nitric-oxide-related signaling that may support repair and vascular responses.

Angiogenesis Related Signaling (Reported Alongside Nitric Oxide Signaling In Preclinical Models)Fibroblast Migration/Repair Signaling Discussed In Wound Healing StudiesNeuroprotection Has Been Explored In Preclinical ContextsGrowth Hormone Receptor Expression Changes In Injured Tissue (Reported In Model Systems)

pH & Mixing

6.4

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Heals stubborn tendon and ligament injuries that won't respond to rest
  • Cuts systemic inflammation fast
  • Repairs gut lining - especially helpful if you've damaged your stomach with NSAIDs
  • Builds new blood vessels to damaged areas (angiogenesis)
  • Protects and heals the stomach lining
  • May help nerve tissue regenerate

Side Effects

  • Injection-site irritation or soreness is the most commonly mentioned effect in limited user reports
  • Transient flushing can occur, but documented cases are sparse
  • No well-established side-effect profile in large human trials

Contraindications

  • Pregnant or breastfeeding women
  • Individuals under 18 years old
  • Those with known allergies to peptide components

Structure & Sequence

View 3D structure

Verified structure

BPC-157

Sequence illustration backed by PubChem match.

Verified via PubChemMatched by casNumber
C62H98N16O221,419.5 DaCAS 137525-51-015 residues
Source: PubChemLookup: 137525-51-0InChIKey HEEWEZGQMLZMFE-RKGINYAYSA-N
Amino Acid Sequence
GKPPPGKPADDAGLV
Molecular Weight
1,419.5 Da
Chemical Formula
C62H98N16O22
CAS Number
137525-51-0
Reconstituted pH
6.4
InChIKey
HEEWEZGQMLZMFE-RKGINYAYSA-N

Stack & Route Context

Stacks with

  • TB-500
  • GHK-Cu
  • Thymosin Alpha-1

Administration

Subcutaneous

Research Status

Research is largely preclinical, with limited human evidence. Effects reported in models are often framed around wound healing, inflammation modulation, and angiogenesis.

Approval Status

Preclinical

Sports Legal

Permitted

References

  1. 1

    Pharmacokinetics, distribution, metabolism, and excretion of BPC 157 in rats and dogs

    2022

    View source
  2. 2

    Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract

    2016

    View source
  3. 3

    Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

    2014

    View source
  4. 4

    BPC 157 and standard angiogenic growth factors: Effects on inflammation and angiogenesis

    2018

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.